Harriet Kamendi PhD
November 4, 2025
The Recall That Shouldn’t Surprise Us Anymore When the FDA recalled certain batches of prazosin hydrochloride—a medication widely used for high blood pressure and PTSD—because of carcinogenic impurities, patients were understandably alarmed. But for toxicologists and product developers, this isn’t shocking.
October 31, 2025
CDC, the U.S. Food and Drug Administration (FDA), state and local health departments, and other clinical and public health partners are continuing to monitor e-cigarette, or vaping, product use-associated lung injury (EVALI).
October 30, 2025
When Discovery Meets Responsibility Scientists in Brazil have discovered a previously unknown coronavirus in bats — one that carries genetic similarities to MERS-CoV, the virus responsible for deadly outbreaks in the Middle East.
(University of Nebraska Medical Center, 2025
) For professionals in biotech, toxicology, and product development, the message is urgent and clear:
October 29, 2025
Mechanism Meets Safety Lynkuet (elinzanetant) is one of the first non-hormonal medicines approved to treat moderate to severe hot flashes and night sweats caused by menopause (EMA, 2025).
It’s a major step forward — and a powerful reminder for developers of one core truth:
